SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 102 400 KRW -1.54%
Market Cap: 8T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SK Biopharmaceuticals Co Ltd
Total Assets Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Total Assets
â‚©723.2B
CAGR 3-Years
13%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Total Assets
â‚©2.9T
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
6%
Hanmi Science Co Ltd
KRX:008930
Total Assets
â‚©1.3T
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
6%
Hanmi Pharm Co Ltd
KRX:128940
Total Assets
â‚©2T
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
7%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Total Assets
â‚©491.4B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
12%
C
Celltrion Pharm Inc
KOSDAQ:068760
Total Assets
â‚©639.8B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
5%

See Also

What is SK Biopharmaceuticals Co Ltd's Total Assets?
Total Assets
723.2B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Total Assets amounts to 723.2B KRW.

What is SK Biopharmaceuticals Co Ltd's Total Assets growth rate?
Total Assets CAGR 5Y
50%

Over the last year, the Total Assets growth was 9%. The average annual Total Assets growth rates for SK Biopharmaceuticals Co Ltd have been 13% over the past three years , 50% over the past five years .

Back to Top